Bioprinting: The Intellectual Property Landscape

  • Robert W. EsmondEmail author
  • Deborah Sterling
Reference work entry
Part of the Reference Series in Biomedical Engineering book series (RSBE)


The patenting of bioprinting techniques to make tissues and organs has quietly been going on for more than a decade. Anyone seeking to develop a product or service based upon bioprinting must be concerned about the patent landscape. This chapter will first discuss the various options available to protect the different aspects of bioprinting. Then, it will provide a summary of the landscape of utility patents that protect innovation in each of the three stages of bioprinting: (i) bioimaging + CAD + blueprint, (ii) bi-oink + bio-paper + bioprinter, and (iii) maturogens + biomonitoring + bioreactor. Lastly, the chapter will discuss certain exceptions to patent infringement for the development of bioprinted tissues and organs.


  1. Mironov V et al (2008) Organ printing: promises and challenges. Regen Med 3:93–103CrossRefPubMedGoogle Scholar
  2. Press Release, Organovo Holdings, Inc., Organovo announces two issued patents, First Company Patent and Key Founder Patent (9 July 2012) (on file with author).

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Biotechnology/Chemical GroupSterne, Kessler, Goldstein & Fox P.L.L.C.WashingtonUSA

Personalised recommendations